Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05967884
Title PD-1 +/- IL-4 Inhibition in ER+ Breast Cancer
Recruitment Not yet recruiting
Gender female
Phase Phase II
Variant Requirements No
Sponsors Ottawa Hospital Research Institute
Indications
Therapies
Age Groups: adult | senior
Covered Countries CAN


No variant requirements are available.